Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients. [electronic resource]
Producer: 20070830Description: 103-11 p. digitalISSN:- 0008-543X
- Agglutination Tests -- methods
- Antibodies -- blood
- Antineoplastic Agents -- adverse effects
- Asparaginase -- immunology
- Child
- Female
- Flow Cytometry -- methods
- Humans
- Male
- Metabolic Clearance Rate
- Polyethylene Glycols -- pharmacokinetics
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- blood
- Reproducibility of Results
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.